שווי שוק לרווח Voyager Corp (VYGR)

The market price trend for Voyager Therapeutics (VYGR) on the GURU.Markets platform is fixed at -1.00, driven by the impact of partnership payments and successful preclinical tests amid stable capital. Voyager Therapeutics is based on the unique TRACER system to overcome the blood-brain barrier in Alzheimer's therapy. Simultaneously, the business is implementing environmental standards for chemical recycling and optimizing its laboratory operations.
פילוחי מדדים מקיפים ואנליטיקה עבור Voyager Therapeutics Inc (VYGR)

To minimize investment risks, it is necessary to compare the issuer's market capitalization with its actual profit. The P/E ratio is calculated as the ratio of the share price to the net profit per share, measuring the investment payback period. By analyzing the company's P/E trend, a strategist determines the extent of the premium paid for future growth. For Voyager Therapeutics (VYGR), this metric reflects the cost of gene therapy innovations and the expenses associated with complex cryogenic vector logistics.